Stericycle Deferred Long Term Liab from 2010 to 2024
| SRCL Stock | USD 61.98 0.51 0.83% |
Deferred Long Term Liabilities | First Reported 2010-06-30 | Previous Quarter 431.8 M | Current Value 429 M | Quarterly Volatility 206.7 M |
Check Stericycle financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Stericycle's main balance sheet or income statement drivers, such as Depreciation And Amortization of 227.3 M, Total Revenue of 1.7 B or Gross Profit of 688 M, as well as many indicators such as Price To Sales Ratio of 1.64, Dividend Yield of 0.0042 or PTB Ratio of 1.72. Stericycle financial statements analysis is a perfect complement when working with Stericycle Valuation or Volatility modules.
Stericycle | Deferred Long Term Liab |
Latest Stericycle's Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of Stericycle over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Stericycle's Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Stericycle's overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
Stericycle Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 329,186,130 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 61.49 | |
| Mean Deviation | 153,342,637 | |
| Median | 371,100,000 | |
| Standard Deviation | 202,413,278 | |
| Sample Variance | 40971.1T | |
| Range | 645.4M | |
| R-Value | 0.51 | |
| Mean Square Error | 32597.7T | |
| R-Squared | 0.26 | |
| Significance | 0.05 | |
| Slope | 23,132,106 | |
| Total Sum of Squares | 573595.9T |
Stericycle Deferred Long Term Liab History
About Stericycle Financial Statements
Stericycle investors utilize fundamental indicators, such as Deferred Long Term Liab, to predict how Stericycle Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 491.1 M | 346.9 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Stericycle Correlation against competitors. For more information on how to buy Stericycle Stock please use our How to buy in Stericycle Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Environmental & Facilities Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stericycle. If investors know Stericycle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stericycle listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.167 | Earnings Share 0.39 | Revenue Per Share 28.384 | Quarterly Revenue Growth (0.01) | Return On Assets 0.023 |
The market value of Stericycle is measured differently than its book value, which is the value of Stericycle that is recorded on the company's balance sheet. Investors also form their own opinion of Stericycle's value that differs from its market value or its book value, called intrinsic value, which is Stericycle's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stericycle's market value can be influenced by many factors that don't directly affect Stericycle's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stericycle's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stericycle is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stericycle's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.